摘要
5α还原酶(5α-R)已被认为广泛地存在于人类和其他动物体内,对5α-RⅠ型(5α-R1)及5α-RⅡ型(5α-R2)的研究表明,它主要将睾酮、孕酮、醛固酮和去氧皮质酮转化成各自的5α肾上腺酮二氢衍生物,进一步转化为活跃的有明显生理功能的神经类固醇激素。目前对5α-RⅢ型(5α-R3)的研究引起广泛关注。5α-R3分布和表达于人类的小脑、视网膜、心脏、皮肤、肾、前列腺、肝、骨、肌肉、子宫肌层和胰腺。尽管表达水平不同,但研究发现其生理及功能不尽相同,对人类智力障碍和视觉障碍的影响已得到证实。5α-R3的发现将为与其相关疾病的发生和发展,如良性前列腺增生(BPH)、前列腺癌、男性雄激素性脱发(AGA)的研究提供了更为广阔的思路和选择。
5α-reductases (5α-R) are a family of isozymes expressed in a wide host of tissues including humans and animals. The studies of 5α-reductase type 1 (5α-R1) and 5α-reductase type 2 (5α-R2) showed that they con- verted testosterone, progesterone, aldosterone and deoxyeorticosterone into their respective 5α-dihydro-derivatives, which were subsequently transformed into a subclass of neuro-active steroid hormones with distinct physio- logical function. The recent studies confirmed that the expression and tissue distribution of 5α-reductase type 3 (5α-Rα) encompassed the hippocampus and cerebellum of human brain, retina, heart, skin, kidney, prostate, liv- er, skeleton, muscle, myometrium, and pancreas. Furthermore, it has been proved the varying degrees of expression levels had different physiological function and evolvement. For instance, patients with 5α-reductases deficiency exhibit mental retardation and visual impairment. The target of 5α-R3 provides a wide strategy and prosperity in the occurrence and development of associative diseases, such as BPH, prostate cancer and androgenetic alopecia (AGA).
出处
《临床泌尿外科杂志》
2015年第1期79-83,共5页
Journal of Clinical Urology
关键词
5α还原酶Ⅲ型
前列腺增生
前列腺癌
5Α还原酶抑制剂
5α-reductase type 3
benign prostatic hyperplasial prostate cancer
5α-reductase inhibition